Disparities by sex in P2Y(12) inhibitor therapy duration, or differences in the balance of ischaemic-benefit and bleeding-risk clinical outcomes in older women versus comparable men following acute myocardial infarction? A P2Y(12) inhibitor new user retrospective cohort analysis of US Medicare claims data

OBJECTIVES: To determine if comparable older women and men received different durations of P2Y(12) inhibitor therapy following acute myocardial infarction (AMI) and if therapy duration differences were justified by differences in ischaemic benefits and/or bleeding risks. DESIGN: Retrospective cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Hickson, Ryan P, Kucharska-Newton, Anna M, Rodgers, Jo E, Sleath, Betsy L, Fang, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638457/
https://www.ncbi.nlm.nih.gov/pubmed/34853104
http://dx.doi.org/10.1136/bmjopen-2021-050236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638457/
https://www.ncbi.nlm.nih.gov/pubmed/34853104
http://dx.doi.org/10.1136/bmjopen-2021-050236

Ejemplares similares